Generex announces USFDA approval of use of company's buccal insulin product

14-Sep-2009 - Generex Biotechnology Corporation announced that the U.S. Food and Drug Administration (FDA) has granted approval for the treatment use of Generex Oral-lyn™ under the FDA’s Treatment Investigational New Drug (IND) program. Under a structured Treatment IND protocol, Generex Oral-lyn ™ will be ...

MU researcher uses bacteria to make radioactive metals inert

Scientist is studying bacteria that could clean contaminated water bodies across the US

10-Sep-2009 - The Lost Orphan Mine below the Grand Canyon hasn't produced uranium since the 1960s, but radioactive residue still contaminates the area. Cleaning the region takes an expensive process that is only done in extreme cases, but Judy Wall, a biochemistry professor at the University of Missouri ...

Evotec starts Phase I with EVT 103, an NR2B-selective NMDA receptor antagonist

09-Sep-2009 - Evotec AG announced the Phase I clinical study initiation for EVT 103, a small molecule NR2B-selective NMDA receptor antagonist. EVT 103 is a next generation molecule following EVT 101, the orally available compound currently planned to enter clinical development for treatment-resistant ...

Plant Impact Appoints New Scientific Advisory Board

08-Sep-2009 - Plant Impact plc announced that a new Scientific Advisory Board (SAB) has been established for the Company. The new SAB consists of seasoned industry professionals with in depth experience of commercial development with key expertise in the areas of agrochemicals and natural plant protectants. ...

Orion and Hospira,Inc. sue Sandoz companies in the U.S. to enforce their U.S. Patents covering the proprietary drug Precedex

08-Sep-2009 - Orion Corporation and Hospira, Inc. filed together a patent infringement lawsuit in the United States to enforce Orion's U.S. Patent No.4,910,214 and Orion's and Hospira's commonly owned U.S. Patent No. 6,716,867 against Sandoz International Gmbh and Sandoz Inc. Sandoz Inc. seeks authorisation ...

Santhera initiates Pivotal Phase III Study with Catena/Sovrima (Idebenone) in Duchenne Muscular Dystrophy

04-Sep-2009 - Santhera Pharmaceuticals and Takeda Pharmaceutical Company Limited announced that Santhera has initiated the pivotal Phase III study with Catena®/Sovrima® (INN: idebenone) for the treatment of Duchenne Muscular Dystrophy. The 12-month DELOS study will enroll up to 240 patients in 25 centers in ...

DxS Enters Into Collaboration With Bristol-Myers Squibb And ImClone Systems To Provide a K-RAS Companion Diagnostic For ERBITUX

04-Sep-2009 - DxS has entered into a collaboration agreement with Bristol-Myers Squibb Company and ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company, to further develop a K-RAS companion diagnostic for ERBITUX® (cetuximab) in the United States and Canada. If approved by the U.S. Food and ...

Rice fragrance origins revealed

Highly valued rice fragrance has origins in basmati rice, study finds

03-Sep-2009 - A new Cornell study reports that the gene that gives rice its highly valued fragrance stems from an ancestor of basmati rice and dispels other long-held assumptions about the origins of basmati. Rice is classified into two major varietal groups: Japonica and Indica, both of which were grown in ...

NIH study reveals new genetic culprit in deadly skin cancer

Sequencing work points to new target for melanoma treatment

02-Sep-2009 - Drawing on the power of DNA sequencing, National Institutes of Health researchers have identified a new group of genetic mutations involved in the deadliest form of skin cancer, melanoma. This discovery is particularly encouraging because some of the mutations, which were found in nearly ...

Platinum nanocatalyst could aid drugmakers

Rice chemists design polymer-coated nanorods for industrial use

02-Sep-2009 - Nanoparticles combining platinum and gold act as superefficient catalysts, but chemists have struggled to create them in an industrially useful form. Rice University chemists have answered the call with a polymer-coated version of gold-platinum nanorods, the first catalysts of their kind that can ...